Victory Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $968M | Buy |
|
|||||
|
2025
Q1 | $142M | Sell |
|
|||||
|
2024
Q4 | $123M | Sell |
|
|||||
|
2024
Q3 | $144M | Sell |
|
|||||
|
2024
Q2 | $153M | Sell |
|
|||||
|
2024
Q1 | $170M | Sell |
|
|||||
|
2023
Q4 | $177M | Sell |
|
|||||
|
2023
Q3 | $201M | Buy |
|
|||||
|
2023
Q2 | $175M | Sell |
|
|||||
|
2023
Q1 | $172M | Buy |
|
|||||
|
2022
Q4 | $143M | Sell |
|
|||||
|
2022
Q3 | $152M | Sell |
|
|||||
|
2022
Q2 | $155M | Buy |
|
|||||
|
2022
Q1 | $138M | Buy |
|
|||||
|
2021
Q4 | $37.4M | Buy |
|
|||||
|
2021
Q3 | $30.1M | Buy |
|
|||||
|
2021
Q2 | $32.2M | Sell |
|
|||||
|
2021
Q1 | $123M | Sell |
|
|||||
|
2020
Q4 | $155M | Buy |
|
|||||
|
2020
Q3 | $150M | Sell |
|
|||||
|
2020
Q2 | $170M | Sell |
|
|||||
|
2020
Q1 | $250M | Buy |
|
|||||
|
2019
Q4 | $76.1M | Buy |
|
|||||
|
2019
Q3 | $25.1M | Buy |
|
|||||
|
2019
Q2 | $3.5M | Buy |
|
|||||
|
2019
Q1 | $3.5M | Buy |
|
|||||
|
2018
Q4 | $625K | Sell |
|
|||||
|
2018
Q3 | $731K | Sell |
|
|||||
|
2018
Q2 | $653K | Sell |
|
|||||
|
2018
Q1 | $639K | Sell |
|
|||||
|
2017
Q4 | $599K | Sell |
|
|||||
|
2017
Q3 | $633K | Sell |
|
|||||
|
2017
Q2 | $553K | Sell |
|
|||||
|
2017
Q1 | $494K | Sell |
|
|||||
|
2016
Q4 | $344K | Sell |
|
|||||
|
2016
Q3 | $413K | Buy |
|
|||||
|
2016
Q2 | $272K | Sell |
|
|||||
|
2016
Q1 | $256K | Sell |
|
|||||
|
2015
Q4 | $416K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $0 | Buy |
|